I
t is a great pleasure to guest edit this issue of Psychiatric Annals, which focuses on the real-world complexities and challenges faced by individuals with bipolar disorder, and by their partners, families, and clinicians.
Although there have been real and impressive advances in both pharmacological and behavioral treatments that can improve health outcomes among people with bipolar disorder, it is clear that the literature evidence-base, particularly medication treatment randomized controlled trials (RCTs), do not specifically inform treatment choices for all patients with bipolar disorder.
In many RCTs, people with comorbid conditions such as substance use disorders and significant medical comorbidity are specifically excluded from trial enrollment. Similarly, pregnant or lactating women are generally not included in most RCTs.
In contrast to the selectivity seen in RCTs, clinicians in realworld settings are tasked with the messy business of helping people with multiple morbidities and challenging circumstances to get symptom relief and ultimately achieve recovery. This can be a daunting challenge.
Fortunately, there is growing awareness that complexity is partand-parcel of living with bipolar disorder. There is an emerging body of literature that addresses this complexity head-on. This special issue features the work of four experts in bipolar disorder research who share their insights on key areas that complicate health outcomes and recovery among people with bipolar disorder.
Erin E. Michalak, PhD, and colleagues from the University of British Columbia address the important issue of recovery from the perspective of the individual living with bipolar disorder (see page 173). As the authors point out, the notion that bipolar disorder is a severe mental illness with a relatively poor prognosis may set the stage for a bleak view that offers little hope for "recovery." The implications of this message for people newly diagnosed can be profound 1 Given that pregnancy appears not to be protective against bipolar disorder 3 and postpartum is a time of potentially increased risk for mood relapse, 4 patients and clinicians need to be well-aware of the risk vs. benefits of treatment.
Bryan K. Tolliver, MD, PhD, and Karen J. Hartwell, MD, discuss bipolar disorder complicated by co-occurring substance use disorder (SUD) (see page 190). It has been reported that 50% to 60% of people with bipolar disorder will develop at least one SUD in their lifetime, and bipolar disorder is the Axis I diagnosis most commonly associated with a comorbid SUD.
5-9 SUD and bipolar disorder share a number of characteristics that present challenges for diagnosis and clinical management. The authors provide a number of pragmatic recommendations based upon emerging lines of evidence.
Taken together, this collection of papers illustrates the range of complexity which exists for patients, families, and clinicians managing bipolar disorder. While the reviews are encouraging in that promising new directions and research are emerging, it is also clear that there is much to be done and new research and information is needed so that treatment decisions can truly be individualized depending on comorbidity and life circumstances. 
